Predicting Patient Outcomes from Single Cells in Childhood Cancer
Kara Davis - Associate Professor of Pediatrics (Hematology & Oncology)
Bio-X Affiliated Faculty
Dr. Davis is a Pediatric Oncologist whose laboratory focuses on studying healthy hematopoietic development and leukemia using single cell analysis methods, including mass cytometry to identify clinically relevant cell populations and drug targets to prevent patient relapse.
Stanford Bio-X Seed Grants
Interdisciplinary Initiatives Program Seed Grant: Enabling the clinical adoption of a B cell activation assay for outcome prediction in childhood leukemia
Interdisciplinary Initiatives Program Round 12 - 2024
Research News
Team science award recognizes eight pediatric cancer researchers
April 29, 2021 - Stanford Medicine News Center
The American Association for Cancer Research’s Team Science Award recognizes the scientific team...